The 6th Qingdao Multinationals Summit to Be Held on June 18, Signaling China’s Commitment to Expanding Opening-Up and Boosting Foreign Investment

QINGDAO, China, June 15, 2025 /PRNewswire/ — A news report from Information Office of the People’s Government of Shandong Province: To help multinational corporations better understand, invest in, and succeed in China, the sixth Qingdao Multinationals Summit (QMS), co-hosted by the Ministry of Commerce of China and the Government of Shandong Province,will be held in Qingdao… Continue reading The 6th Qingdao Multinationals Summit to Be Held on June 18, Signaling China’s Commitment to Expanding Opening-Up and Boosting Foreign Investment

Tokyo Gas Wins CNCF End User Case Study Contest for Driving Cloud Native Agility with Kubernetes, Argo and Istio

Company to present digital platform modernization success at KubeCon + CloudNativeCon Japan 2025 TOKYO, June 15, 2025 /PRNewswire/ — The Cloud Native Computing Foundation® (CNCF®), which builds sustainable ecosystems for cloud native software, today announced Tokyo Gas as the winner of the CNCF End User Case Study Contest. Selected for its innovative use of Kubernetes, Argo… Continue reading Tokyo Gas Wins CNCF End User Case Study Contest for Driving Cloud Native Agility with Kubernetes, Argo and Istio

Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

HONG KONG, June 15, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) (“Akeso” or the “Company”)  presented the subgroup analysis data from the Phase III COMPASSION-16 trial, evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody, in the first-line treatment of advanced, recurrent, or metastatic cervical cancer. The data was featured as an oral presentation at the 2025 American… Continue reading Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

Global Times: Scholars’ Perspectives: Five-year plans important experience of CPC in governance: scholar who participated in formulating plans

BEIJING, June 15, 2025 /PRNewswire/ — The scientific formulation and consistent implementation of five-year plans stand as an important piece of experience in the Communist Party of China’s (CPC) approach to governing the country. It’s also significantly representing the political advantage of socialism with Chinese characteristics. On May 19, Chinese President Xi Jinping, also general secretary… Continue reading Global Times: Scholars’ Perspectives: Five-year plans important experience of CPC in governance: scholar who participated in formulating plans

ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

SHANGHAI, June 15, 2025 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the National Medical Products Administration (NMPA) has officially accepted its New Drug Application (NDA) for Azstarys (serdexmethylphenidate/dexmethylphenidate extended-release capsules) and granted it Priority Review designation. The investigational therapeutic drug is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients… Continue reading ArkBio’s New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA

Stavian Chemical Climbs to Top 15 in ICIS Top 100 Global Chemical Distributors 2025

HANOI, Vietnam, June 15, 2025 /PRNewswire/ — Stavian Chemical, a leading global chemical distributor and manufacturer, proudly announces its advancement to 15th place in the prestigious ICIS Top 100 Global Chemical Distributors 2025 ranking, up from 17th in 2024. The company also maintains its stronghold as one of the Top 7 distributors in the Asia-Pacific (APAC)… Continue reading Stavian Chemical Climbs to Top 15 in ICIS Top 100 Global Chemical Distributors 2025

Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China

SAN FRANCISCO and SUZHOU, China, June 15, 2025 /PRNewswire/ — Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major disease areas, announced that the first participant has been successfully dosed in a Phase 3 clinical… Continue reading Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China

Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Approval of 45mg/0.5mL solution in a single-dose vial for subcutaneous injection expands dosing flexibility for pediatric patients with plaque psoriasis (PsO) or psoriatic arthritis (PsA) under 60kg The FDA previously approved STEQEYMA® 45mg/0.5mL, 90mg/mL in a single-dose prefilled syringe for subcutaneous injection, and 130mg/26mL in a single-dose vial for intravenous infusion in December 2024 STEQEYMA… Continue reading Celltrion announces U.S. FDA approval of additional presentation of STEQEYMA® (ustekinumab-stba), expanding dosing options for pediatric patients

Samsung Biologics launches drug screening services, Samsung Organoids

Samsung Organoids to provide data-driven analysis of candidate molecules Samsung Biologics expands service scope to include preclinical research INCHEON, South Korea, June 15, 2025 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the launch of Samsung Organoids – advanced drug screening services to support clients in drug… Continue reading Samsung Biologics launches drug screening services, Samsung Organoids

2025 Meijer LPGA Classic for Simply Give Exceeds Goal, Raising $1.5 Million to Fight Hunger and Feed Communities in Need

GRAND RAPIDS, Mich., June 15, 2025 /PRNewswire/ — The 11th Meijer LPGA Classic for Simply Give concluded today, crowning Carlota Ciganda as its 2025 champion. The event, held at Blythefield Country Club in Belmont, Mich., featured an exciting four days of top-tier golf and extraordinary community impact. Continue Reading The 11th Meijer LPGA Classic for Simply… Continue reading 2025 Meijer LPGA Classic for Simply Give Exceeds Goal, Raising $1.5 Million to Fight Hunger and Feed Communities in Need